Daniel Johansson currently serves as a Medical Advisor for Rare Disease in the Nordics at Ipsen, beginning in November 2023. Prior experience includes roles as Nordic Medical Advisor and Launch Lead at Vifor Pharma, Nordic Medical Science Liaison at Kyowa Kirin International plc., and Senior Medical Science Liaison at Novartis, focusing on cardiometabolics and heart failure. Daniel has contributed significantly to medical affairs through leadership in studies and mentoring junior colleagues. Academic credentials include a PhD in Experimental Medicine from Karolinska Institutet, with additional training in Medical Affairs from IFAPP/King’s College London and a Master Work from Harvard Medical School. Daniel's early career involved research collaborations and a postdoctoral position at Karolinska Institutet, studying the roles of antibodies and B cells in various diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices